Galderma Group Ltd header image

Galderma Group Ltd

GALD

Equity

ISIN CH1335392721 / Valor 133539272

SIX Swiss Exchange (2026-03-06)

CHF 156.00+0.71%

Galderma Group Ltd
UMushroom community rating:

4.33 3 votes No rating yet

NegativeNeutralPositive

About company

Galderma Group Ltd is a leading company in the dermatology sector, focusing exclusively on this field for over 40 years. The company specializes in developing, manufacturing, and marketing a wide range of dermatological treatments and solutions. Galderma's product portfolio includes therapeutic dermatology products, dermatological skincare, and injectable aesthetic treatments, catering to a diverse range of skin health needs. With a global presence, the company operates research and development centers and manufacturing facilities strategically located around the world. Galderma is dedicated to advancing the field of dermatology through continuous innovation and science-based solutions, aiming to enhance the quality of life for patients with various skin conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

53.9%1Y

%3Y

%5Y

Performance

35.1%1Y

30.9%3Y

30.9%5Y

Volatility

47179 M

Market cap (USD)

436,499

Daily traded volume (Shares)

100.6 / 98.35

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.33

3 votes

Performance:

4.00

Innovation:

4.00

Society:

3.00

Nature:

2.67

Laura Bischofberger

Switzerland, 12 Jun 2024

New kid on the block, lets see where they go after they IPO.

Hein Sweerts de Landas

Switzerland, 12 Jun 2024

It's the trend, personal beautification. Online: photoshop, real world: Galderma!

Lea Katunaric

Switzerland, 12 Jun 2024

Was never too keen on this type of procedures.

EQUITIES OF THE SAME SECTOR

Astrana Health Inc

Astrana Health Inc Valor: 28041888

Annual Return

-50%0%+50%

Risk level

110

-0.64%USD 24.91

AEVIS VICTORIA SA

AEVIS VICTORIA SA Valor: 47863410

Annual Return

-50%0%+50%

Risk level

110

1.12%CHF 13.50

Attendo AB

Attendo AB Valor: 30491576

Annual Return

-50%0%+50%

Risk level

110

0.97%SEK 103.80

Venture Life Group PLC

Venture Life Group PLC Valor: 23084203

Annual Return

-50%0%+50%

Risk level

110

-2.19%GBP 0.67

Robertet SA

Robertet SA Valor: 510354

Annual Return

-50%0%+50%

Risk level

110

-0.24%EUR 825.00

Ramsay Generale de Sante SA

Ramsay Generale de Sante SA Valor: 1247709

Annual Return

-50%0%+50%

Risk level

110

1.88%EUR 10.85

Resmed Inc

Resmed Inc Valor: 321632

Annual Return

-50%0%+50%

Risk level

110

-0.96%USD 252.87

BridgeBio Pharma Inc

BridgeBio Pharma Inc Valor: 48204826

Annual Return

-50%0%+50%

Risk level

110

-1.22%USD 65.36

Dyne Therapeutics Inc

Dyne Therapeutics Inc Valor: 56806425

Annual Return

-50%0%+50%

Risk level

110

-2.24%USD 14.86

OKYO Pharma Limited

OKYO Pharma Limited Valor: 127195533

Annual Return

-50%0%+50%

Risk level

110

-1.78%USD 1.66

SIX

FactSet

Clearbit

Logos provided by Clearbit